{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T20:47:49Z","timestamp":1772743669721,"version":"3.50.1"},"reference-count":68,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2002,6,17]],"date-time":"2002-06-17T00:00:00Z","timestamp":1024272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cathet Cardio Intervent"],"published-print":{"date-parts":[[2002,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Despite the availability of antiplatelet and antithrombotic therapies, recent advances in catheter and stent technology and improved operator skill, restenosis remains the most frequent problem associated with percutaneous and surgical revascularization interventions for both coronary and peripheral arterial disease. Prevention of restenosis in the coronary vasculature has been demonstrated with cilostazol, trapidil, probucol, tranilast, nitric oxide donors, and clopidogrel. Given the similarities in revascularization procedures and in the pathophysiology of restenosis, it is possible that these results may be extrapolated to the setting of restenosis in the peripheral vasculature, making trials with these agents imperative. Several new agents have shown promising preliminary results for the prevention of restenosis in the peripheral vasculature, including cilostazol, low\u2010molecular\u2010weight heparins, and elastase. Several nonpharmacologic treatment modalities are also under study to prevent peripheral and coronary restenosis and have shown favorable initial results. These include endovascular radiation brachytherapy, arterial gene therapy, photoangioplasty, and several novel treatment delivery systems. Cathet Cardiovasc Intervent 2002;56:421\u2013431. \u00a9 2002 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/ccd.10211","type":"journal-article","created":{"date-parts":[[2002,10,6]],"date-time":"2002-10-06T12:43:37Z","timestamp":1033908217000},"page":"421-431","source":"Crossref","is-referenced-by-count":16,"title":["Potential emerging therapeutic strategies to prevent restenosis in the peripheral vasculature"],"prefix":"10.1002","volume":"56","author":[{"given":"Robert M.","family":"Schainfeld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,6,17]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.88.4.1534"},{"issue":"1","key":"e_1_2_8_3_2","first-page":"S1","article-title":"Management of peripheral arterial disease (PAD)","volume":"31","author":"TransAtlantic Inter\u2010Society Consensus (TASC) Working Group","year":"2000","journal-title":"J Vasc Surg"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(96)00498-6"},{"key":"e_1_2_8_5_2","first-page":"552","article-title":"The three processes leading to post PTCA restenosis: dependence on the lesion substrate","volume":"71","author":"Fuster V","year":"1995","journal-title":"Thromb Haemost"},{"key":"e_1_2_8_6_2","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1055\/s-0037-1615577","article-title":"Prevention of restenosis after percutaneous coronary interventions: the medical approach","volume":"82","author":"Rosanio S","year":"1999","journal-title":"Thromb Haemost"},{"key":"e_1_2_8_7_2","first-page":"142","article-title":"Myointimal hyperplasia: basic science and clinical considerations","volume":"11","author":"Neville RF","year":"1998","journal-title":"Semin Vasc Surg"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.1.21"},{"key":"e_1_2_8_9_2","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/00005344-199212000-00009","article-title":"Effects of cilostazol, a cyclic AMP phosphodiesterase inhibitor, on the proliferation of rat aortic smooth muscle cells in culture","volume":"20","author":"Takahashi S","year":"1992","journal-title":"J Cardiovasc Pharmacol"},{"key":"e_1_2_8_10_2","first-page":"143","article-title":"The potential of cilostazol in interventional cardiology","volume":"2","author":"Tsuchikane E","year":"2000","journal-title":"Curr Intervent Cardiol Rep"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(97)85458-7"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(98)70327-8"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(97)00052-0"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0304(199808)44:4<387::AID-CCD4>3.0.CO;2-0"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(97)80058-6"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)00501-9"},{"key":"e_1_2_8_17_2","first-page":"II","article-title":"A randomized comparison of cilostazol vs. ticlopidine after coronary stent implantation","volume":"102","author":"Mizoguchi K","year":"2000","journal-title":"Circulation"},{"key":"e_1_2_8_18_2","first-page":"I","article-title":"Comparison of cilostazol with ticlopidine after Palmaz\u2010Schatz stent implantation: a prospective randomized trial","volume":"98","author":"Hayashi T","year":"1998","journal-title":"Circulation"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)00579-2"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)00368-9"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00045415-199907000-00014"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(92)90792-T"},{"key":"e_1_2_8_23_2","first-page":"I53","article-title":"Preventive effects of trapidil (PDGF antagonist) on restenosis after PTCA","volume":"86","author":"Nishikawa H","year":"1992","journal-title":"Circulation"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.90.6.2710"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199708073370601"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(97)00270-2"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(98)00323-3"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(95)92396-M"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(97)70055-3"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(95)90227-9"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.91.6.1689"},{"key":"e_1_2_8_32_2","first-page":"I","article-title":"Double blind, controlled trial of the effect of angiopeptin on coronary restenosis following balloon angioplasty","volume":"88","author":"Kent KM","year":"1993","journal-title":"Circulation"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.95.1.83"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)09457-3"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.6.624"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.119.1_suppl.283S"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002700010064"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0741-5214(99)70109-6"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2168.1999.01193.x"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.1053\/ejvs.1999.1034"},{"key":"e_1_2_8_41_2","doi-asserted-by":"publisher","DOI":"10.1053\/ejvs.1999.1039"},{"key":"e_1_2_8_42_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.19408"},{"key":"e_1_2_8_43_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004424-199509000-00004"},{"key":"e_1_2_8_44_2","first-page":"527","article-title":"Comparison of cilostazol with warfarin as antithrombotic therapy after femoro\u2010popliteal bypass surgery using an ePTFE graft","volume":"45","author":"Ohtake H","year":"1997","journal-title":"Minerv Cardioangiol"},{"key":"e_1_2_8_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)92269-1"},{"key":"e_1_2_8_46_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002709900283"},{"key":"e_1_2_8_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(96)00343-9"},{"key":"e_1_2_8_48_2","first-page":"94","article-title":"Effect of elastase on primary graft patency after femoralpopliteal arterial bypass for arteriosclerosis obliterans: a randomized, controlled study","volume":"82","author":"Fujioka K","year":"1997","journal-title":"Int Surg"},{"key":"e_1_2_8_49_2","first-page":"268","article-title":"Effect of pancreatopeptidase E (Elastase) on the suppression of intimal fibrous proliferation after arterial reconstruction in high cholesterol\u2010fed rabbits","volume":"29","author":"O\u2010hara M","year":"1988","journal-title":"J Cardiovasc Surg"},{"key":"e_1_2_8_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-821X(05)80240-3"},{"key":"e_1_2_8_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1078-5884(96)80258-9"},{"key":"e_1_2_8_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1053-4296(99)80009-5"},{"key":"e_1_2_8_53_2","first-page":"18A","article-title":"Vascular brachytherapy: update on clinical trials","volume":"12","author":"Waksman R","year":"2000","journal-title":"J Invas Cardiol"},{"key":"e_1_2_8_54_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01102065"},{"key":"e_1_2_8_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(96)00435-X"},{"key":"e_1_2_8_56_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.22.2694"},{"key":"e_1_2_8_57_2","first-page":"I66","article-title":"Intravascular radiation for prevention of restenosis after angioplasty of narrowed femoral\u2010popliteal arteries: Preliminary six month results of a feasibility study","volume":"98","author":"Waksman R","year":"1999","journal-title":"Circulation"},{"key":"e_1_2_8_58_2","doi-asserted-by":"publisher","DOI":"10.1089\/hum.1996.7.8-989"},{"key":"e_1_2_8_59_2","first-page":"I66","article-title":"Arterial gene therapy for inhibiting restenosis in patients with claudication undergoing superficial femoral artery angioplasty","volume":"98","author":"Vale PR","year":"1999","journal-title":"Circulation"},{"issue":"2","key":"e_1_2_8_60_2","first-page":"S64","article-title":"Induction of p\u201053 mediated apoptosis and local hepatocyte growth factor (HGF) by cyclic AMP accumulation in human aortic VSMC","volume":"16","author":"Hayashi S","year":"1998","journal-title":"J Hypertens"},{"key":"e_1_2_8_61_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199609000-00004"},{"key":"e_1_2_8_62_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.5.591"},{"key":"e_1_2_8_63_2","first-page":"67","article-title":"Use of locally delivered conventional drug therapies","volume":"1","author":"Camezind E","year":"1996","journal-title":"Semin Intervent Cardiol"},{"key":"e_1_2_8_64_2","first-page":"I346","article-title":"Local heparin delivery following balloon angioplasty to prevent restenosis: preliminary results of an open multicenter registry","volume":"92","author":"Camezind E","year":"1995","journal-title":"Circulation"},{"key":"e_1_2_8_65_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.103.1.26"},{"key":"e_1_2_8_66_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.93.3.412"},{"key":"e_1_2_8_67_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.103.2.192"},{"key":"e_1_2_8_68_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002709900309"},{"key":"e_1_2_8_69_2","first-page":"91","article-title":"Electro\u2010encapsulating drugs within blood platelets: local delivery to injured arteries during angioplasty","volume":"1","author":"Crawford N","year":"1996","journal-title":"Semin Intervent Cardiol"}],"container-title":["Catheterization and Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fccd.10211","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ccd.10211","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T20:49:55Z","timestamp":1697057395000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ccd.10211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6,17]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,7]]}},"alternative-id":["10.1002\/ccd.10211"],"URL":"https:\/\/doi.org\/10.1002\/ccd.10211","archive":["Portico"],"relation":{},"ISSN":["1522-1946","1522-726X"],"issn-type":[{"value":"1522-1946","type":"print"},{"value":"1522-726X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,6,17]]}}}